T6 Genetic characterisation of pseudomonas aeruginosa isolates from bronchiectasis patients in a randomized, double-blind placebo-controlled trial of a bispecific monoclonal antibody targeting Psl and PcrV (GREAT-2)
Year: 2025
Type: conference-paper
Authors: RC Hull, MB Long, A Gilmour, I Petrou, R Galloway, K Viligorska, H Richardson, JM New, C Hennayake, E Johnson, E McIntosh, Z Eke, M Band, H Bandara, G Martin, S Aliberti, M Vendrell, E Polverino, G Suarez-Cuartin, MR Loebinger, M Tunney, K Cartwright, R Hughes, A DiGiandomenico, MG Belvisi, W Brailsford, C Haworth, O Sibila, J Stobo, JD Chalmers
Institutions: University of Dundee, Humanitas University, Universitat de Girona, Institut d'Investigació Biomèdica de Girona, Vall d'Hebron Hospital Universitari, Bellvitge University Hospital, Guy's and St Thomas' NHS Foundation Trust, Royal Brompton Hospital, Queen's University Belfast, AstraZeneca (United Kingdom), AstraZeneca (United States), AstraZeneca (Sweden), Papworth Hospital NHS Foundation Trust, Hospital Clínic de Barcelona
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4416134553